SINT (SINTX Technologies) Cyclically Adjusted Revenue per Share: $327.13 (As of Mar. 2026)


SINT SINTX Technologies Inc SINT
23 GF Score
Price $1.90
GF Value $0.15
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is SINTX Technologies Cyclically Adjusted Revenue per Share?

SINTX Technologies SINT +2.15% 23 Cyclically Adjusted Revenue per Share is $327.13 as of Mar. 2026. GuruFocus rates SINT with a GF Score™ of 23/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

SINTX Technologies's adjusted revenue per share for the three months ended in Mar. 2026 was $0.075. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $327.13 for the trailing ten years ended in Mar. 2026.

During the past 12 months, SINTX Technologies's average Cyclically Adjusted Revenue Growth Rate was -13.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -17.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of SINTX Technologies was -17.40% per year. The lowest was -17.40% per year. And the median was -17.40% per year.

As of today (2026-07-02), SINTX Technologies's current stock price is $1.90. SINTX Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $327.13. SINTX Technologies's Cyclically Adjusted PS Ratio of today is 0.01.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of SINTX Technologies was 20.12. The lowest was 0.01. And the median was 0.02.


SINTX Technologies  (NAS:SINT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

SINTX Technologies's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.90/327.13
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of SINTX Technologies was 20.12. The lowest was 0.01. And the median was 0.02.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


SINTX Technologies Cyclically Adjusted Revenue per Share Related Terms


SINTX Technologies Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for SINTX Technologies's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SINTX Technologies Cyclically Adjusted Revenue per Share Chart

SINTX Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 592.60 474.02 390.75 334.39

SINTX Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 377.12 363.10 349.73 334.39 327.13

SINT vs ALRTF, CODX, PMI: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, SINTX Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SINTX Technologies Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where SINTX Technologies's Cyclically Adjusted PS Ratio falls into.


SINT
23GF Score
SINTX Technologies Inc SINT
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SINTX Technologies Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SINTX Technologies's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.075/330.2130*330.2130
=0.075

Current CPI (Mar. 2026) = 330.2130.

SINTX Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 0.000 246.524 0.000
201803 0.000 249.554 0.000
201806 0.000 251.989 0.000
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 0.000 254.202 0.000
201906 0.000 256.143 0.000
201909 0.000 256.759 0.000
201912 0.000 256.974 0.000
202003 207.000 258.115 264.820
202006 204.000 257.797 261.304
202009 66.000 260.280 83.733
202012 116.000 260.474 147.058
202103 101.000 264.877 125.913
202106 101.000 271.696 122.753
202109 239.000 274.310 287.707
202112 165.000 278.802 195.426
202203 101.000 287.504 116.004
202206 80.000 296.311 89.153
202209 173.000 296.808 192.471
202212 82.333 296.797 91.603
202303 18.462 301.836 20.198
202306 10.682 305.109 11.561
202309 7.636 307.789 8.192
202312 21.593 306.746 23.245
202403 1.797 312.332 1.900
202406 0.542 314.175 0.570
202409 0.409 315.301 0.428
202412 0.143 315.605 0.150
202503 0.164 319.799 0.169
202506 0.039 322.561 0.040
202509 0.051 324.800 0.052
202512 0.049 324.054 0.050
202603 0.075 330.213 0.075

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $327.13 mean?
SINTX Technologies (SINT) has a Cyclically Adjusted Revenue per Share of $327.13 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on SINTX Technologies and its competitors.
Is SINTX Technologies' Cyclically Adjusted Revenue per Share too high?
SINTX Technologies' current Cyclically Adjusted Revenue per Share is $327.13. Overall, SINTX Technologies has a GF Score™ of 23/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SINTX Technologies' Cyclically Adjusted Revenue per Share compare to ALRTF and CODX?
SINTX Technologies' Cyclically Adjusted Revenue per Share of $327.13 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on SINTX Technologies and its competitors. SINTX Technologies's current Cyclically Adjusted Revenue per Share is $327.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SINTX Technologies stock overvalued right now?
Based on GuruFocus' analysis, SINTX Technologies (SINT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $1.90 — trading 1166.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $327.13. SINTX Technologies' overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For SINTX Technologies (SINT), the current Cyclically Adjusted Revenue per Share is $327.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SINTX Technologies (SINT) Overvalued in 2026?

Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued. The current stock price of $1.90 is trading 1166.7% above its estimated GF Value™ of $0.15. GuruFocus considers SINTX Technologies to be Significantly Overvalued.

Key valuation signals for SINT:

  • Cyclically Adjusted Revenue per Share: $327.13
  • GF Value™: $0.15 vs. price of $1.90 (1166.7% above fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SINTX Technologies Business Description

Other Exchanges 0A8S:UK
Address 1885 West 2100 South, Salt Lake City, UT, USA, 84119
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
23GF Score

Get the complete analysis for SINT

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.90
Price
$0.15
GF Value